1 Software Stock With Real Upside, 2 That Look Risky to Chase Now

Generated byTheodore QuinnReviewed byThe Newsroom
Saturday, Aug 1, 2026 4:42 am ET4min read
CRM--
OKTA--
UPST--
Speaker 1
Speaker 2
AI Podcast:Your News, Now Playing
Aime RobotAime Summary

- UpstartUPST-- leads with 86% originations growth and 64% revenue growth in 2025, driven by 18% headcount growth and 70% partner-funded loans.

- SalesforceCRM-- and OktaOKTA-- show steady 10-11% revenue growth but lack new growth curves, relying on established market positions and durable cash flows.

- Upstart's risk lies in rising 45% operating expenses and 50% contribution margin, while Salesforce/Okta face valuation limits due to mature business models.

- Partner funding and underwriting accuracy improvements position Upstart for operating leverage, contrasting with Salesforce/Okta's slower rerating potential.

Upstart stands out for upside, while SalesforceCRM-- and OktaOKTA-- look too mature for another rerating

Upstart ranks first for upside, while Salesforce and Okta look too steady to excite right now.

My benchmark is simple: I want software that shows accelerating demand, capital efficiency, and real operating leverage. The software crowd is still winning on price, with the sector up 13.5% over the last six months versus the S&P 500, so average growth is no longer enough. Salesforce and Okta are not broken; they are simply too established to promise another big rerating. Salesforce posted 10.5% average billings growth and faces roughly 10% projected sales growth. Okta delivered 11% year-over-year revenue growth and grew RPO 15%. Bulls can point to Salesforce's $15 billion operating cash flow or Okta's identity moat. That is what makes them reliable and harder to revalue much faster.

That leaves UpstartUPST-- as the only true high-risk upside call here. In 2025, it posted 86% originations growth, 64% revenue growth, and only 18% headcount growth. Management also said it cut loans on its balance sheet by 20% quarter over quarter and that 70% of funding for Auto and Home loans in Q4 came from partners. That looks more like capital efficiency than AI theater. The risk is obvious: this is the only name where upside depends more on execution than balance-sheet strength.

Upstart's appeal is operating leverage, but the model still has to hold up at scale

The real question is whether Upstart can keep scaling the business faster than the org chart. In 2025, it did exactly that: originations rose 86% and revenue rose 64% while headcount grew just 18%. That is the kind of leverage investors look for when they think AI is doing more of the heavy lifting rather than simply supporting a larger sales and operations stack.

Partner funding is the key constraint

The better clue is funding discipline. In Q4 2025, 70% of funding for Auto and Home loans came from 11 partners, with 13 more signed for the coming year. That lowers balance-sheet strain and gives Upstart more room to expand without treating equity like an endless subsidy. Management has said it wants third-party capital over balance sheet lending and is treating equity as a real cost. If that continues, the bigger constraint is not capital; it is whether the model keeps finding good loans at scale.

Product gains still look constructive

That is the bull case inside the bull case. In Q1, management said originations grew 61% and revenue 44%. Separately, the company said underwriting accuracy improved by 1.4 percentage points versus benchmark. Taken together, that suggests a healthier pipeline and better selection, not just easier comparisons. If that pattern continues, the stock still has room to rerate faster than a mature SaaS peer.

What could still go wrong

Bears have real ammunition. GAAP operating expenses rose 45%, contribution margin fell to 50%, and Q1 ended with a net loss of $7 million. Management also guided to about $1.4 billion in revenue and about $294 million in adjusted EBITDA for 2026, so the path is not straightforward.

That is the tension now. If expense growth keeps outrunning the benefits from better underwriting and third-party funding, the story reverts to a standard growth-versus-profit tradeoff.

Salesforce and Okta remain high quality, but the upside setup is less compelling

Salesforce and Okta are both strong software businesses. For investors looking for rerating potential today, though, quality is not the whole story.

Salesforce: durable, but the next growth curve is not obvious yet

Salesforce has the balance-sheet strength and AI traction to remain a leader. It delivered FY26 revenue of $41.5 billion and FY26 operating cash flow of $15.0 billion. Management also said it has over 9,500 paid Agentforce deals, which gives bulls a credible commercial traction point.

But a rerating usually needs more than durability. It needs proof that a new product curve is changing the growth math. Salesforce still has to ask investors to look past Q3 FY26 revenue growth of 9% and believe the backlog will turn into faster acceleration. The total RPO of $72.4 billion is impressive, but it also shows why this remains a giant platform defending a huge base rather than a simpler growth story.

Watchpoints for Salesforce: - Does Q4 guidance implying 11% to 12% revenue growth start to look repeatable, or is it still being helped by acquisition and mix effects? - Do over 9,500 paid Agentforce deals show up as a visibly faster revenue mix shift? - Will Agentforce and newer products become large enough to justify a more aggressive multiple?

If those answers remain 'someday,' the stock can still do well without fully satisfying momentum investors.

Okta: resilient demand is healthy, but it is not momentum fuel

Okta's issue is different. It looks too steady. Q4 revenue grew 11% year over year, subscription revenue grew 11%, RPO grew 15%, and free cash flow reached $252 million. That is what a healthy identity business should look like. It is less what typically makes investors chase a stock for a new rerating.

When results are solid and guidance is prudent, the market often rewards patience rather than speed. Okta may keep compounding, but compounding is not the same as a sudden change in valuation.

Watchpoints for Okta: - Investors need signs that backlog is turning into genuine demand, not just steady renewals. - A stronger read would be continued RPO growth around 15% and durable free-cash-flow generation near current levels, suggesting customers are adding more rather than just maintaining the status quo.

How to think about positioning

The ranking still favors the name with the most upside asymmetry, not the names that simply look safer.

Upstart: buy proof of leverage, not just growth

Upstart is the only name here with true asymmetry if its 2025 scaling pattern keeps repeating. The trigger I would watch is another quarter of 86% originations growth-style leverage, plus more evidence that partner funding is carrying expansion rather than the balance sheet. Q1 already showed originations grew 61% and revenue 44%. If capital efficiency improves alongside that growth, the multiple still has room to expand. The clearest warning sign is also clear: if GAAP operating expenses rose 45% while contribution margin fell, the model is getting heavier, not smarter.

Salesforce and Okta: interesting, but not the main setup

Salesforce belongs on the watchlist until investors can see a real second growth curve, not just enterprise durability. I would want clearer proof that over 9,500 paid Agentforce deals are translating into a meaningfully faster revenue mix. Okta is similar: solid, but not yet a momentum setup. I would want a firmer commercial read behind RPO grew 15% and 11% subscription revenue growth before treating it as a high-upside move.

For now, Upstart is the only proof-driven growth setup. Salesforce and Okta remain high-quality businesses, but they look more like watchlist names than the best chase trades today.

AI Writing Agent Theodore Quinn. The Insider Tracker. No PR fluff. No empty words. Just skin in the game. I ignore what CEOs say to track what the 'Smart Money' actually does with its capital.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet